Daily BriefsMost Read

Most Read: Zijin Gold, Raksul Inc, Tsuruha Holdings, Almonty Industries, Applied Materials, Planet Labs, Hang Seng Bank, Mandom Corp, Medical Data Vision and more

In today’s briefing:

  • Gold Miners ETF (GDX US) Dec Rebalance: 5 Adds and US$8.8bn Trade; Zijin Gold Added
  • [Japan M&A] CEO & Chairman Entice GS to Sponsor an MBO for Recently Lackluster Raksul (4384)
  • [Japan Partial Tender] AEON (8267) Tender for TSURUHA (3391) Trading Rich
  • MV Global Rare Earth/​​​​​Strategic Metals Index Rebalance: 3 Adds and Other Changes; US$550m Trade
  • [Japan M&A?] Nikkei Reports Nippon Life to Buy Medical Data Vision (3902) For ~¥60bn
  • MV US Listed Semiconductor 25 Index Rebalance: Capping Leads to US$5.5bn Trade
  • MV Global Defense Industry Index Rebalance: 4 Adds; 5.8% Turnover; US$850m Trade
  • Hang Seng (11 HK): 8th Jan Vote On HSBC’s Offer. Clean Deal.
  • Mandom (4917 JP): When You Thought It Was Done, KKR Emerges as a Competing Bidder
  • [Japan M&A] Nippon Life Shoots the Lights Out with a Bid at ¥1,693


Gold Miners ETF (GDX US) Dec Rebalance: 5 Adds and US$8.8bn Trade; Zijin Gold Added

By Brian Freitas

  • There are 5 additions for the VanEck Gold Miners ETF/USA (GDX US) in December. Zijin Gold (2259 HK) is a surprise add (as are some of the others).
  • Estimated one-way turnover is 15.2% and that leads to a round-trip trade of US$8.8bn. There are many stocks with multiple days of ADV to trade from passive trackers.
  • The MarketVector Global Gold Miners Index has just passed its earlier highs, but a lot of the adds have broken out and are trading much higher than their prior highs.

[Japan M&A] CEO & Chairman Entice GS to Sponsor an MBO for Recently Lackluster Raksul (4384)

By Travis Lundy

  • Raksul Inc (4384 JP) is a business roll-up business. They do printing, and advertising, and marketing, and supply. They want to be all things to all SMEs. 
  • They are pretty good at it. Revenues and EBIT have been growing at 20-30% a year for years, and are scheduled to grow 19% and 26% for several years ahead.
  • The bid is up 40% from last, but that gets them to a 30-month high. The register is very open. Lots of active institutional shareholders who have to agree. Maybe.

[Japan Partial Tender] AEON (8267) Tender for TSURUHA (3391) Trading Rich

By Travis Lundy


MV Global Rare Earth/​​​​​Strategic Metals Index Rebalance: 3 Adds and Other Changes; US$550m Trade

By Brian Freitas


[Japan M&A?] Nikkei Reports Nippon Life to Buy Medical Data Vision (3902) For ~¥60bn

By Travis Lundy

  • Medical Data Vision (3902 JP) was IPOed in 2014. MitCorp sold. Others sold. Fujifilm and Medipal stayed in. The stock ran up. SBI bought from Fujifilm in Nov2020 at ¥2355.
  • The stock fell, SBI bought more in 2021-2022. Then it fell more in 2023 and SBI bought more, then fell more in 2024 and SBI bought more. 
  • The Nikkei reports today that Nippon Life will announce a TOB on 15 December with a max price of ¥60bn (242% premium), which coincidentally would bring SBI close to breakeven.

MV US Listed Semiconductor 25 Index Rebalance: Capping Leads to US$5.5bn Trade

By Brian Freitas


MV Global Defense Industry Index Rebalance: 4 Adds; 5.8% Turnover; US$850m Trade

By Brian Freitas

  • BigBear.ai Holdings, NextVision Stabilized Systems, Ondas Holdings Inc and Planet Labs will be added to the MarketVector Global Defense Industry Index at the close on 19 December.
  • The 4 adds, float changes and capping changes will result in an estimated one-way turnover of 5.8% resulting in a round-trip trade of US$846m.
  • The adds have all run up over the last year and the passive buying could give the stocks another leg up in the short-term.

Hang Seng (11 HK): 8th Jan Vote On HSBC’s Offer. Clean Deal.

By David Blennerhassett

  • Back on the 9th October, Hang Seng Bank (11 HK) announced an Offer from controlling parent, HSBC Holdings (5 HK), by way of a Scheme.
  • HSBC offered HK$155/share, a 30.3% premium to last close. The price was final. A third interim dividend was bolted on. Optically – and fundamentally – the price was bang on.
  • The Scheme Doc is now out, with the Court Meeting on the 8th January 2026.  Payment around 4th Feb. The IFA, in a bare-bones report, concluded “fair & reasonable”. 

Mandom (4917 JP): When You Thought It Was Done, KKR Emerges as a Competing Bidder

By Arun George

  • Mandom Corp (4917 JP) has disclosed that it has received a non-binding letter of intent from a third-party candidate, with purchase prices exceeding the CVC JPY2,520 offer.
  • The Nikkei identifies the bidder as KKR and states that the offer is over JPY2,800, a 11.1% premium to the CVC offer. KKR want a Board-recommended offer.
  • CVC has extended the close of its offer to 5 January 2026, but will need to revise terms as its irrevocables (particularly Murakami and Hibiki) can switch to KKR.

[Japan M&A] Nippon Life Shoots the Lights Out with a Bid at ¥1,693

By Travis Lundy

  • Over the weekend the Nikkei reported that Nippon Life would bid ¥60bn for Medical Data Vision (3902 JP). At one price per share, that meant ¥1,585.  
  • There is a deemed dividend treatment buyback for SBI at ¥1,189 which means they will end up with a capital loss (their in-price is ¥1,630) but they’ll offset that.
  • This is the biggest win for minorities in a long while. Be happy.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars